Patents by Inventor Ana L. Moore

Ana L. Moore has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7922891
    Abstract: The present invention relates to a method for detecting and quantitating NADH/NAD+ and/or NADPH/NADP+ as well as NADHJNAD+ and/or NADPH/NADP+ dependent enzymes using a photoelectrochemical cell.
    Type: Grant
    Filed: May 24, 2004
    Date of Patent: April 12, 2011
    Assignee: Arizona Board of Regents
    Inventors: John Devens Gust, Jr., Ana L. Moore, Thomas A. Moore, Alicia Brune
  • Patent number: 6826321
    Abstract: Excitation of a triad artificial photosynthetic reaction center consisting of a porphyrin (P) convalently linked to a fullerene electron acceptor (C60) and a carotenoid secondary donor (C) leads to the formation of a long-lived C+-P-C60− charge-separated state via photoinduced electron transfer. This reaction occurs in a frozen organic glass down to at least 8 K. At 77 K, charge recombination of C*+-P-C60− occurs on the &mgr;s time scale, and yields solely the carotenoid triplet state. In the presence of a small (20 mT) static magnetic field, the lifetime of the charge-separated state is increased by 50%. This is ascribed to the effect of the magnetic field on interconversion of the singlet and triplet biradicals. At zero field, the initially formed singlet biradical state is in equilibrium with the three triplet biradical sublevels, and all four states have comparable populations. Decay to the carotenoid triplet only occurs from the three triplet sublevels.
    Type: Grant
    Filed: March 30, 2001
    Date of Patent: November 30, 2004
    Assignee: Arizona Board of Regents
    Inventors: John D. Gust, Jr., Ana L. Moore, Thomas A. Moore
  • Patent number: 6419897
    Abstract: A process of pathology or target tissue identification comprising administering an imaging material to a pathology or target tissue bearing mammalian host and irradiating the mammalian host with electromagnetic radiation having a wavelength between about 600 and 1100 nm, and especially in the region of 700 nm and longer wavelengths, whereupon the imaging material, which has been preferentially taken up by the pathology or target tissue, emits light and permits precise identification of the location, size and/or shape of the pathology or target tissue.
    Type: Grant
    Filed: July 25, 2000
    Date of Patent: July 16, 2002
    Assignee: Arizona Board of Regents
    Inventors: John Devens Gust, Jr., Ana L. Moore, Thomas A. Moore, William H. Ralston
  • Patent number: 6274729
    Abstract: A process of pathology or target tissue identification comprising administering an imaging material to a pathology or target tissue bearing mammalian host and irradiating the mammalian host with electromagnetic radiation having a wavelength between about 600 and 1100 nm, and especially in the region of 700 nm and longer wavelengths, whereupon the imaging material, which has been preferentially taken up by the pathology or target tissue, emits light and permits precise identification of the location, size and/or shape of the pathology or target tissue.
    Type: Grant
    Filed: February 1, 2000
    Date of Patent: August 14, 2001
    Assignee: Arizona Board of Regents
    Inventors: John Devens Gust, Jr., Ana L. Moore, Thomas A. Moore, William H. Ralston
  • Patent number: 6207821
    Abstract: A process of pathology or target tissue identification comprising administering an imaging material to a pathology or target tissue bearing mammalian host and irradiating the mammalian host with electromagnetic radiation having a wavelength between about 600 and 1100 nm, and especially in the region of 700 nm and longer wavelengths, whereupon the imaging material, which has been preferentially taken up by the pathology or target tissue, emits light and permits precise identification of the location, size and/or shape of the pathology or target tissue.
    Type: Grant
    Filed: February 1, 2000
    Date of Patent: March 27, 2001
    Assignee: Arizona Board of Regents
    Inventors: John Devens Gust, Jr., Ana L. Moore, Thomas A. Moore, William H. Ralston
  • Patent number: 6183727
    Abstract: A process of pathology or target tissue identification comprising administering an imaging material to a pathology or target tissue bearing mammalian host and irradiating the mammalian host with electromagnetic radiation having a wavelength between about 600 and 1100 nm, and especially in the region of 700 nm and longer wavelengths, whereupon the imaging material, which has been preferentially taken up by the pathology or target tissue, emits light and permits precise identification of the location, size and/or shape of the pathology or target tissue.
    Type: Grant
    Filed: April 1, 1999
    Date of Patent: February 6, 2001
    Assignee: Arizona Board of Regents
    Inventors: John Devens Gust, Jr., Ana L. Moore, Thomas A. Moore, William H. Ralston
  • Patent number: 5286474
    Abstract: A process of tumor identification comprising administering a carotenoporphyrin to a tumor-bearing mammalian host and irradiating the mammalian host with light whereupon the carotenoporphyrin, which has been preferentially taken up by the tumor tissue, fluoresces and permits precise identification of the location, size and shape of the tumor tissue. An improved process of synthesizing carotenoporphyrins 1-5 is also provided.
    Type: Grant
    Filed: October 22, 1992
    Date of Patent: February 15, 1994
    Assignee: Arizona Board of Regents, a body corporate, acting for and on behalf the Arizona State University
    Inventors: John D. Gust, Jr., Ana L. Moore, Thomas A. Moore, Giulio Jori, Elena Reddi
  • Patent number: RE41693
    Abstract: Excitation of a triad artificial photosynthetic reaction center consisting of a porphyrin (P) convalently linked to a fullerene electron acceptor (C60) and a carotenoid secondary donor (C) leads to the formation of a long-lived C+-P-C60? charge-separated state via photoinduced electron transfer. This reaction occurs in a frozen organic glass down to at least 8 K. At 77 K, charge recombination of C*+-P-C60? occurs on the ?s time scale, and yields solely the carotenoid triplet state. In the presence of a small (20 mT) static magnetic field, the lifetime of the charge-separated state is increased by 50%. This is ascribed to the effect of the magnetic field on interconversion of the singlet and triplet biradicals. At zero field, the initially formed singlet biradical state is in equilibrium with the three triplet biradical sublevels, and all four states have comparable populations. Decay to the carotenoid triplet only occurs from the three triplet sublevels.
    Type: Grant
    Filed: November 30, 2006
    Date of Patent: September 14, 2010
    Assignee: Arizona Board of Regents, Acting for and on Behalf of, Arizona State University
    Inventors: John D. Gust, Jr., Ana L. Moore, Thomas Moore